{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T22:01:29Z","timestamp":1790892089257,"version":"4.1.0"},"reference-count":244,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.ijpharm.2019.02.026","type":"journal-article","created":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T11:36:37Z","timestamp":1551180997000},"page":"47-65","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":87,"special_numbering":"C","title":["How to characterize a nasal product. The state of the art of in vitro and ex vivo specific methods"],"prefix":"10.1016","volume":"561","author":[{"given":"Laurent","family":"Salade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Wauthoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Goole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"Amighi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2019.02.026_b0005","first-page":"64","article-title":"Preparation and evaluation of transnasal microemulsion of carbamazepine","volume":"8","author":"Acharya","year":"2013","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0010","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1530\/eje.0.1500447","article-title":"Pharmacokinetics, safety, and endocrine and appetite effects of ghrelin administration in young healthy subjects","volume":"150","author":"Akamizu","year":"2004","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/8727289","article-title":"Effect of high, medium, and low molecular weight hyaluronan on inflammation and oxidative stress in an in vitro model of human nasal epithelial cells","volume":"2016","author":"Albano","year":"2016","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0020","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2478\/v10007-009-0038-3","article-title":"Permeation of losartan across human respiratory epithelium: an in vitro study with Calu-3 cells","volume":"59","author":"Amoako-Tuffour","year":"2009","journal-title":"Acta Pharmaceut."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0025","series-title":"Olfaction","author":"Amoore","year":"1971"},{"key":"10.1016\/j.ijpharm.2019.02.026_b0030","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.jnnfm.2010.07.005","article-title":"Effect of artificial mucus properties on the characteristics of airborne bioaerosol droplets generated during simulated coughing","volume":"165","author":"Anwarul Hasan","year":"2010","journal-title":"J. Nonnewton. Fluid Mech."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0035","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1080\/10717540802006922","article-title":"Effect of cyclodextrins on the complexation and nasal permeation of melatonin","volume":"15","author":"Babu","year":"2008","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0040","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ejpb.2017.11.001","article-title":"Intranasal immunization with dry powder vaccines","volume":"122","author":"Bahamondez-Canas","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0045","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1002\/jps.21031","article-title":"Evaluation of human nasal RPMI 2650 cells grown at an air\u2013liquid interface as a model for nasal drug transport studies","volume":"97","author":"Bai","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0050","doi-asserted-by":"crossref","first-page":"10519","DOI":"10.1039\/c2ra20702h","article-title":"Preparation and evaluation of the effect of particle size on the properties of chitosan-montmorillonite nanoparticles loaded with isoniazid","volume":"2","author":"Banik","year":"2012","journal-title":"RSC Adv."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0055","doi-asserted-by":"crossref","first-page":"428","DOI":"10.4103\/0250-474X.108418","article-title":"Preparation and characterisation of mucoadhesive nasal gel of venlafaxine hydrochloride for treatment of anxiety disorders","volume":"74","author":"Basu","year":"2012","journal-title":"Indian J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0060","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0378-5173(92)90235-T","article-title":"The viability of isolated rabbit nasal mucosa in the Ussing chamber, and the permeability of insulin across the membrane","volume":"87","author":"Bechgaard","year":"1992","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0065","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jconrel.2016.04.014","article-title":"Mechanisms allowing protein delivery in nasal mucosa using NPL nanoparticles","volume":"232","author":"Bernocchi","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2019.02.026_b0070","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ejps.2005.08.005","article-title":"In situ gelling, bioadhesive nasal inserts for extended drug delivery: in vitro characterization of a new nasal dosage form","volume":"27","author":"Bertram","year":"2006","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0075","first-page":"Doc07","article-title":"Physiology and pathophysiology of respiratory mucosa of the nose and the paranasal sinuses","volume":"9","author":"Beule","year":"2010","journal-title":"GMS Curr. Top. Otorhinolaryngol Head Neck Surg."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0080","doi-asserted-by":"crossref","DOI":"10.4103\/0973-8398.45032","article-title":"Bioavailability of intranasal drug delivery system","volume":"2","author":"Bhise","year":"2008","journal-title":"Asian J. Pharm."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0190319","article-title":"Predicting apparent passive permeability of Caco-2 and MDCK cell-monolayers: a mechanistic model","author":"Bittermann","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ijpharm.2019.02.026_b0090","series-title":"Models for Assessing Drug Absorption and Metabolism","author":"Borchardt","year":"1996"},{"key":"10.1016\/j.ijpharm.2019.02.026_b0095","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1208\/s12249-011-9678-y","article-title":"Formulation and evaluation of in situ gelling systems for intranasal administration of gastrodin","volume":"12","author":"Cai","year":"2011","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijpharm.2019.02.026_b0100","doi-asserted-by":"crossref","first-page":"702","DOI":"10.2500\/ajr.2007.21.3107","article-title":"Nasal scraping in diagnosing ciliary dyskinesia","volume":"21","author":"Caruso","year":"2007","journal-title":"Am. J. Rhinol."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0105","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jconrel.2014.05.003","article-title":"Chitosan in nasal delivery systems for therapeutic drugs","volume":"190","author":"Casettari","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2019.02.026_b0110","doi-asserted-by":"crossref","first-page":"215","DOI":"10.4103\/2231-4040.90876","article-title":"A review on mucoadhesive polymer used in nasal drug delivery system","volume":"2","author":"Chaturvedi","year":"2011","journal-title":"J. Adv. Pharm. Technol. Res."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0115","article-title":"Enhanced nasal mucosal delivery and immunogenicity of anti-caries DNA vaccine through incorporation of anionic liposomes in chitosan\/DNA complexes","volume":"8","author":"Chen","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ijpharm.2019.02.026_b0120","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/jcsm.12023","article-title":"Ghrelin prevents tumour- and cisplatin-induced muscle wasting: characterization of multiple mechanisms involved","volume":"6","author":"Chen","year":"2015","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"key":"10.1016\/j.ijpharm.2019.02.026_b0125","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1089\/08942680152484199","article-title":"Characterization of nasal spray pumps and deposition pattern in a replica of the human nasal airway","volume":"14","author":"Cheng","year":"2001","journal-title":"J. Aerosol Med."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0130","series-title":"In-vitro Investigation of Factors Affecting the Fate of Dry Powders in the Lung","author":"Cingolani","year":"2017"},{"key":"10.1016\/j.ijpharm.2019.02.026_b0135","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ijpharm.2016.07.002","article-title":"Nasal powders of thalidomide for local treatment of nose bleeding in persons affected by hereditary hemorrhagic telangiectasia","volume":"514","author":"Colombo","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0140","first-page":"373","article-title":"Regional deposition of beclomethasone dipropionate powder existing Puvlizer\u00ae in a nasal cast connected to a next generation impactor","volume":"2","author":"Coowanitwong","year":"2011","journal-title":"RDD Eur."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0145","unstructured":"Costin, G.-E., Raabe, H. & Curren, R., 2009. In vitro safety testing strategy for skin irritation using the 3D reconstructed human epidermis."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0150","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1152\/physiologyonline.1997.12.5.219","article-title":"Endocytosis of polypeptides in rabbit nasal respiratory mucosa","volume":"12","author":"Cremaschi","year":"1997","journal-title":"Physiology"},{"key":"10.1016\/j.ijpharm.2019.02.026_b0155","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1208\/s12249-013-0036-0","article-title":"The effect of moisture on the flowability of pharmaceutical excipients","volume":"15","author":"Crouter","year":"2014","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijpharm.2019.02.026_b0160","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.addr.2008.09.005","article-title":"Nanoparticles for nasal vaccination","volume":"61","author":"Csaba","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0165","series-title":"Nanoparticulate vaccine delivery systems","author":"D\u2019Souza","year":"2015"},{"key":"10.1016\/j.ijpharm.2019.02.026_b0170","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0169-409X(01)00162-4","article-title":"Nasal vaccines","volume":"51","author":"Davis","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0175","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/jps.20090","article-title":"Evaluation of different parameters that affect droplet-size distribution from nasal sprays using the Malvern Spraytec\u00ae","volume":"93","author":"Dayal","year":"2004","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0180","first-page":"194","article-title":"Evaluation of the human cell line RPMI 2650 as an in vitro nasal model","volume":"33","author":"De Fraissinette","year":"1995","journal-title":"Rhinology"},{"key":"10.1016\/j.ijpharm.2019.02.026_b0185","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.micpath.2017.12.011","article-title":"Preparation, characterization and immunological evaluation of alginate nanoparticles loaded with whole inactivated influenza virus: dry powder formulation for nasal immunization in rabbits","volume":"115","author":"Dehghan","year":"2018","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0190","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s13346-012-0108-9","article-title":"Nasal drug delivery devices: characteristics and performance in a clinical perspective\u2014a review","volume":"3","author":"Djupesland","year":"2013","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0195","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0378-5173(95)04115-X","article-title":"Bioadhesive and formulation parameters affecting nasal absorption","volume":"127","author":"Dondeti","year":"1996","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0200","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1007\/s11095-012-0804-7","article-title":"Measurement of drug in small particles from aqueous nasal sprays by andersen cascade impactor","volume":"29","author":"Doub","year":"2012","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0205","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3109\/03639045.2010.520321","article-title":"Automated actuation of nasal spray products: determination and comparison of adult and pediatric settings","volume":"37","author":"Doughty","year":"2011","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0210","first-page":"341","article-title":"Physical properties of sputum. VII. Rheologic properties and mucociliary transport","volume":"112","author":"Dulfano","year":"1975","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0215","series-title":"Drug Absorption Studies: In Situ, In Vitro and In Silico Models","year":"2008"},{"key":"10.1016\/j.ijpharm.2019.02.026_b0220","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1172\/JCI115407","article-title":"Killing of gram-negative bacteria by lactoferrin and lysozyme","volume":"88","author":"Ellison","year":"1991","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0225","doi-asserted-by":"crossref","first-page":"2","DOI":"10.5339\/gcsp.2015.2","article-title":"Inhaled nano- and microparticles for drug delivery","volume":"2015","author":"El-Sherbiny","year":"2015","journal-title":"Glob. Cardiol. Sci. Pract."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0230","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1046\/j.1365-2273.1999.00223.x","article-title":"Nasal pH measurement: a reliable and repeatable parameter","volume":"24","author":"England","year":"1999","journal-title":"Clin. Otolaryngol. Allied Sci."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0235","unstructured":"EVOM2: Instruction Manual. Word Precis. Instruments."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0240","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1208\/s12249-013-9956-y","article-title":"Formulation and in vitro evaluation of salbutamol sulphate in situ gelling nasal inserts","volume":"14","author":"Farid","year":"2013","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijpharm.2019.02.026_b0245","unstructured":"FDA & CDER, 2003. Guidance for Industry Bioavailability and Bioequivalence Studies for Nasal Aerosols and Nasal Sprays for Local Action."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0250","unstructured":"FDA, 2012. Guidance for Industry Nasal Spray and Inhalation Solution, Suspension, and Spray Drug Products. 20857."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0255","unstructured":"FDA, 2003. Bioavailability and Bioequivalence Studies for Nasal Aerosols and Nasal Sprays for Local Action. 20857, pp. 301\u2013827."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0260","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1590\/S0100-879X2001000500012","article-title":"Effects of formaldehyde on the frog\u2019s mucociliary epithelium as a surrogate to evaluate air pollution effects on the respiratory epithelium","volume":"34","author":"Fl\u00f3-Neyret","year":"2001","journal-title":"Brazilian J. Med. Biol. Res."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0265","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1089\/jam.2007.0638","article-title":"The influence of spray properties on intranasal deposition","volume":"20","author":"Foo","year":"2007","journal-title":"J. Aerosol Med."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5173(00)00452-X","article-title":"Characterization of the Calu-3 cell line as a tool to screen pulmonary drug delivery","volume":"208","author":"Foster","year":"2000","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0275","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1073\/pnas.1411030112","article-title":"Temperature-dependent innate defense against the common cold virus limits viral replication at warm temperature in mouse airway cells","volume":"112","author":"Foxman","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0280","series-title":"Pharmaceutical Manufacturing Handbook\u202f: Production and Processes","author":"Gad","year":"2008"},{"key":"10.1016\/j.ijpharm.2019.02.026_b0285","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3390\/pharmaceutics10030116","article-title":"Tailoring formulations for intranasal nose-to-brain delivery: a review on architecture, physico-chemical characteristics and mucociliary clearance of the nasal olfactory mucosa","volume":"10","author":"G\u00e4nger","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijpharm.2019.02.026_b0290","doi-asserted-by":"crossref","first-page":"3482","DOI":"10.1016\/j.biomaterials.2006.01.038","article-title":"Lectin-conjugated PEG\u2013PLA nanoparticles: preparation and brain delivery after intranasal administration","volume":"27","author":"Gao","year":"2006","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijpharm.2019.02.026_b0295","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1017\/S0022215100133882","article-title":"An animal model for training in endoscopic nasal and sinus surgery","volume":"110","author":"Gardiner","year":"1996","journal-title":"J. Laryngol. Otol."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0300","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1002\/jps.21267","article-title":"Calibration of the andersen cascade impactor for the characterization of nasal products","volume":"97","author":"Garmise","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0305","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ijpharm.2015.12.046","article-title":"Nanoparticle transport across in vitro olfactory cell monolayers","volume":"499","author":"Gartziandia","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0310","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1211\/0022357055623","article-title":"Mucoadhesive microspheres for nasal administration of an antiemetic drug, metoclopramide: in-vitro\/ex-vivo studies","volume":"57","author":"Gavini","year":"2005","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0315","series-title":"Gibaldi\u2019s Drug Delivery Systems in Pharmaceutical Care","author":"Gibaldi","year":"2007"},{"key":"10.1016\/j.ijpharm.2019.02.026_b0320","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1080\/10717544.2018.1428242","article-title":"In vivo nose-to-brain delivery of the hydrophilic antiviral ribavirin by microparticle agglomerates","volume":"25","author":"Giuliani","year":"2018","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0325","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0169-409X(93)90015-V","article-title":"The relevance of nasal physiology to the design of drug absorption studies","volume":"11","author":"Gizurarson","year":"1993","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0330","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1248\/bpb.b14-00398","article-title":"The effect of cilia and the mucociliary clearance on successful drug delivery","volume":"38","author":"Gizurarson","year":"2015","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0335","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2016.09.086","article-title":"Application of RPMI 2650 as a cell model to evaluate solid formulations for intranasal delivery of drugs","volume":"515","author":"Gon\u00e7alves","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0340","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1007\/s11095-006-0255-0","article-title":"Culture of Calu-3 cells at the air interface provides a representative model of the airway epithelial barrier","volume":"23","author":"Grainger","year":"2006","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0345","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1001\/jamafacial.2016.0215","article-title":"Estimation of nasal tip support using computer-aided design and 3-dimensional printed models","volume":"18","author":"Gray","year":"2016","journal-title":"JAMA Facial Plast. Surg."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0350","series-title":"The Olfactory Mucosa of Vertebrates","first-page":"27","author":"Graziadei","year":"1971"},{"key":"10.1016\/j.ijpharm.2019.02.026_b0355","doi-asserted-by":"crossref","DOI":"10.1089\/jamp.2016.1328","article-title":"Elucidation of formulation and delivery device-related effects on in vitro performance of nasal spray with implication to rational product specification identification","author":"Grma\u0161","year":"2017","journal-title":"J. Aerosol Med. Pulm. Drug Deliv."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0360","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1515\/acph-2016-0047","article-title":"Preparation and in vivo evaluation of a gel-based nasal delivery system for risperidone","volume":"66","author":"Gu","year":"2016","journal-title":"Acta Pharm."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0365","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2500\/ajra.2012.26.3716","article-title":"Acquired cilia dysfunction in chronic rhinosinusitis","volume":"26","author":"Gudis","year":"2012","journal-title":"Am. J. Rhinol. Allergy"},{"key":"10.1016\/j.ijpharm.2019.02.026_b0370","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1002\/jps.20678","article-title":"The influence of actuation parameters on in vitro testing of nasal spray products","volume":"95","author":"Guo","year":"2006","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0375","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1007\/s11095-005-7391-9","article-title":"The effect of formulation variables and breathing patterns on the site of nasal deposition in an anatomically correct model","volume":"22","author":"Guo","year":"2005","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0380","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.ejps.2008.09.001","article-title":"Assessment of the influence factors on in vitro testing of nasal sprays using Box-Behnken experimental design","volume":"35","author":"Guo","year":"2008","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0385","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1211\/0022357011778197","article-title":"Interpretation of mucoadhesive properties of polymer gel preparations using a tensile strength method","volume":"53","author":"H\u00e4gerstr\u00f6m","year":"2001","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0390","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1080\/01926230600713475","article-title":"The nose revisited: a brief review of the comparative structure, function, and toxicologic pathology of the nasal epithelium","volume":"34","author":"Harkema","year":"2006","journal-title":"Toxicol. Pathol."},{"issue":"2","key":"10.1016\/j.ijpharm.2019.02.026_b0395","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0089675","article-title":"Culture of primary ciliary dyskinesia epithelial cells at air-liquid interface can alter ciliary phenotype but remains a robust and informative diagnostic aid","volume":"9","author":"Hirst","year":"2014","journal-title":"PLos One"},{"key":"10.1016\/j.ijpharm.2019.02.026_b0400","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0045-7930(01)00097-4","article-title":"Numerical simulation of the flow field in a model of the nasal cavity","volume":"32","author":"H\u00f6rschler","year":"2003","journal-title":"Comput. Fluids"},{"key":"10.1016\/j.ijpharm.2019.02.026_b0405","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/jps.2600740605","article-title":"Mechanism of nasal absorption of drugs I: physicochemical parameters influencing the rate of in situ nasal absorption of drugs in rats","volume":"74","author":"Huang","year":"1985","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0410","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1243\/09544119JEIM423","article-title":"Development of a nasal cast model to test medicinal nasal devices","volume":"222","author":"Hughes","year":"2008","journal-title":"Proc. Inst. Mech. Eng. Part H J. Eng. Med."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0415","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3109\/10611869609015963","article-title":"Nasal delivery. The use of animal models to predict performance in man","volume":"3","author":"Illum","year":"1996","journal-title":"J. Drug Target."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0420","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1211\/0022357022539","article-title":"Is nose-to-brain transport of drugs in man a reality?","volume":"56","author":"Illum","year":"2004","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0425","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1089\/jam.2006.19.92","article-title":"Nasal clearance in health and disease","volume":"19","author":"Illum","year":"2006","journal-title":"J. Aerosol Med."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0430","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1023\/A:1018901302450","article-title":"Chitosan as a novel nasal delivery system for peptide drugs","volume":"11","author":"Illum","year":"1994","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0435","unstructured":"Impactors for Nasal Spray Testing. Available at: http:\/\/www.copleyscientific.com\/home\/inhaler-testing\/aerodynamic-particle-size\/impactors-for-testing-nasal-delivery-systems. (Accessed: 19th September 2018)."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0440","first-page":"17","article-title":"Factors influencing ciliary beat measurements","volume":"29","author":"Ingels","year":"1991","journal-title":"Rhinology"},{"key":"10.1016\/j.ijpharm.2019.02.026_b0445","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.compbiomed.2008.03.008","article-title":"Optimising nasal spray parameters for efficient drug delivery using computational fluid dynamics","volume":"38","author":"Inthavong","year":"2008","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0450","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/02786826.2011.617793","article-title":"External and near-nozzle spray characteristics of a continuous spray atomized from a nasal spray device","volume":"46","author":"Inthavong","year":"2012","journal-title":"Aerosol Sci. Technol."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0455","doi-asserted-by":"crossref","first-page":"711","DOI":"10.3109\/02652040802685241","article-title":"Formulation and evaluation of nasal mucoadhesive microspheres of Sumatriptan succinate","volume":"26","author":"Jain","year":"2009","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0460","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/10717540490280750","article-title":"Development and characterization of mucoadhesive microspheres bearing salbutamol for nasal delivery","volume":"11","author":"Jain","year":"2004","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0465","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/0091-6749(84)90403-2","article-title":"Human respiratory mucus","volume":"73","author":"Kaliner","year":"1984","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0470","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.ijpharm.2016.08.022","article-title":"A design of experiment approach to predict product and process parameters for a spray dried influenza vaccine","volume":"511","author":"Kanojia","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0475","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1080\/10717540802006377","article-title":"Permeation studies and histological examination of sheep nasal mucosa following administration of different nasal formulations with or without absorption enhancers","volume":"15","author":"Karasulu","year":"2008","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0480","series-title":"Study of Mucoadhesive Microsphere of Pirfenidone for Nasal Drug Delivery","author":"Kashikar","year":"2014"},{"key":"10.1016\/j.ijpharm.2019.02.026_b0485","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0378-5173(97)00364-5","article-title":"The effect of a viscosity and an absorption enhancer on the intra nasal absorption of metoprolol in rats","volume":"163","author":"Kilian","year":"1998","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0490","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/s41598-017-18561-x","article-title":"Enhanced nasal drug delivery efficiency by increasing mechanical loading using hypergravity","volume":"8","author":"Kim","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0495","unstructured":"Kippax, P., Krarup, H., Suman, J.D., 2004. Application for Droplet Sizing: Manual Versus Automated Actuation of Nasal Sprays, 28."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0500","series-title":"Particle Size Characterisation in Nasal Sprays and Aerosols","author":"Kippax","year":"2003"},{"key":"10.1016\/j.ijpharm.2019.02.026_b0505","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s11095-014-1494-0","article-title":"The characterization of the human nasal epithelial cell line RPMI 2650 under different culture conditions and their optimization for an appropriate in vitro nasal model","volume":"32","author":"Kreft","year":"2015","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0510","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jddst.2015.12.004","article-title":"In vitro, ex vivo and in vivo performance of chitosan-based spray-dried nasal mucoadhesive microspheres of diltiazem hydrochloride","volume":"31","author":"Kulkarni","year":"2016","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0515","first-page":"10","article-title":"Formulation and characterization of nasal sprays. An examination of nasal spray formulation parameters and excipients and their influence on key in vitro tests","author":"Kulkarni","year":"2012","journal-title":"Inhalation"},{"key":"10.1016\/j.ijpharm.2019.02.026_b0520","doi-asserted-by":"crossref","DOI":"10.2174\/2211738505666170515113936","article-title":"Intranasal drug delivery: a non-invasive approach for the better delivery of neurotherapeutics","volume":"5","author":"Kumar","year":"2018","journal-title":"Pharm. Nanotechnol."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0525","article-title":"Nasal-nanotechnology: revolution for efficient therapeutics delivery","volume":"1\u201313","author":"Kumar","year":"2014","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0530","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1007\/s11095-011-0417-6","article-title":"Effect of formulation- and administration-related variables on deposition pattern of nasal spray pumps evaluated using a nasal cast","volume":"28","author":"Kundoor","year":"2011","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0535","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s11095-013-1157-6","article-title":"Validation of anatomical models to study aerosol deposition in human nasal cavities","volume":"31","author":"Le Guellec","year":"2014","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0540","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1080\/10717540500177009","article-title":"Air-liquid interface culture of serially passaged human nasal epithelial cell monolayer for in vitro drug transport studies","volume":"12","author":"Lee","year":"2005","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0545","doi-asserted-by":"crossref","first-page":"40249","DOI":"10.1038\/srep40249","article-title":"Sinonasal delivery of resveratrol via mucoadhesive nanostructured microparticles in a nasal polyp mouse model","volume":"7","author":"Lee","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0550","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0168-3659(88)90021-1","article-title":"The contribution of anionic polymer structural features to mucoadhesion","volume":"5","author":"Leung","year":"1987","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2019.02.026_b0555","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/jps.20541","article-title":"Carbopol-mediated paracellular transport enhancement in Calu-3 cell layers","volume":"95","author":"Li","year":"2006","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0560","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.apsb.2016.04.001","article-title":"Nose-to-brain delivery of macromolecules mediated by cell-penetrating peptides","volume":"6","author":"Lin","year":"2016","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ijpharm.2019.02.026_b0565","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1001\/jamafacial.2013.2480","article-title":"Analyzing nasal septal deviations to develop a new classification system: a computed tomography study using MATLAB and OsiriX","volume":"16","author":"Lin","year":"2014","journal-title":"JAMA Facial Plast. Surg."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0570","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1046\/j.1365-2273.2002.00544.x","article-title":"Nasal mucosal temperature during respiration","volume":"27","author":"Lindemann","year":"2002","journal-title":"Clin. Otolaryngol. Allied Sci."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0575","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ijpharm.2009.12.041","article-title":"Evaluation of droplet velocity and size from nasal spray devices using phase Doppler anemometry (PDA)","volume":"388","author":"Liu","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0580","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/jps.2600760502","article-title":"Effects of sodium taurodihydrofusidate on nasal absorption of insulin in sheep","volume":"76","author":"Longenecker","year":"1987","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0585","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.xphs.2015.12.016","article-title":"Development and evaluation of a novel intranasal spray for the delivery of amantadine","volume":"105","author":"Lungare","year":"2016","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0590","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1211\/jpp.61.09.0012","article-title":"Rapid absorption of sumatriptan powder and effects on glyceryl trinitrate model of headache following intranasal delivery using a novel bi-directional device","volume":"61","author":"Luthringer","year":"2009","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0595","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3109\/10717544.2013.838014","article-title":"Nanoemulsion-based intranasal drug delivery system of saquinavir mesylate for brain targeting","volume":"21","author":"Mahajan","year":"2014","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0600","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1164\/ajrccm.160.2.9805117","article-title":"Effect of Biochemical Components on Rheologic Properties of Nasal Mucus in Chronic Sinusitis","volume":"160","author":"Majima","year":"1999","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0605","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1164\/ajrccm\/141.1.79","article-title":"Effects of orally administered drugs on dynamic viscoelasticity of human nasal mucus","volume":"141","author":"Majima","year":"1990","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0610","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1089\/jamp.2009.0766","article-title":"Characterization of stability and nasal delivery systems for immunization with nanoemulsion-based vaccines","volume":"23","author":"Makidon","year":"2010","journal-title":"J. Aerosol Med. Pulm. Drug Deliv."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0615","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1042\/bst0060607","article-title":"A colorimetric assay for glycoproteins based on the periodic acid\/Schiff stain [proceedings]","volume":"6","author":"Mantle","year":"1978","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0620","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1080\/02652048.2016.1260659","article-title":"Resveratrol solid lipid microparticles as dry powder formulation for nasal delivery, characterization and in vitro deposition study","volume":"33","author":"Martignoni","year":"2016","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0625","series-title":"Drug Development \u2013 A Case Study Based Insight into Modern Strategies","article-title":"Multi-dose container for nasal and ophthalmic drugs: a preservative free future?","author":"Marx","year":"2011"},{"key":"10.1016\/j.ijpharm.2019.02.026_b0630","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jpha.2016.05.003","article-title":"Development of a physiologically relevant dripping analytical method using simulated nasal mucus for nasal spray formulation analysis","volume":"6","author":"Masiuk","year":"2016","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0635","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/10611860290007504","article-title":"Permeability characteristics of Calu-3 human bronchial epithelial cells: in vitro \u2013 in vivo correlation to predict lung absorption in rats","volume":"10","author":"Mathias","year":"2002","journal-title":"J. Drug Target"},{"key":"10.1016\/j.ijpharm.2019.02.026_b0640","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/jps.2600760709","article-title":"Analysis of structural requirements for the absorption of drugs and macromolecules from the nasal cavity","volume":"76","author":"McMartin","year":"1987","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0645","unstructured":"Meeting at Washington. United States Pharmacopoeia, National Formulary. By authority of united state Pharmacopoeia Convention, Inc., 2004."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0650","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0135690","article-title":"Permeation of therapeutic drugs in different formulations across the airway epithelium in vitro","volume":"10","author":"Meindl","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ijpharm.2019.02.026_b0655","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ijpharm.2016.11.055","article-title":"Nasal drug delivery: design of a novel mucoadhesive and in situ gelling polymer","volume":"517","author":"Menzel","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0660","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0169-409X(97)00059-8","article-title":"Nasal mucociliary clearance as a factor in nasal drug delivery","volume":"29","author":"Merkus","year":"1998","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0665","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.ejpb.2008.06.013","article-title":"Optimization of the aerosolization properties of an inhalation dry powder based on selection of excipients","volume":"70","author":"Minne","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0670","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1089\/jam.2006.19.409","article-title":"Laser diffractometry as a technique for the rapid assessment of aerosol particle size from inhalers","volume":"19","author":"Mitchell","year":"2006","journal-title":"J. Aerosol Med."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0675","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/1097-0142(196402)17:2<170::AID-CNCR2820170206>3.0.CO;2-N","article-title":"Studies of a human tumor cell line with a diploid karyotype","volume":"17","author":"Moore","year":"1964","journal-title":"Cancer"},{"key":"10.1016\/j.ijpharm.2019.02.026_b0680","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ijpharm.2018.06.058","article-title":"A modified USP induction port to characterize nasal spray plume geometry and predict turbinate deposition under flow","volume":"548","author":"Moraga-Espinoza","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0685","series-title":"The Olfactory Pigment","first-page":"59","author":"Moulton","year":"1971"},{"key":"10.1016\/j.ijpharm.2019.02.026_b0690","first-page":"249","article-title":"Development and characterization of mucoadhesive microspheres for nasal delivery of ketorolac","volume":"66","author":"Nagda","year":"2011","journal-title":"Pharmazie"},{"key":"10.1016\/j.ijpharm.2019.02.026_b0695","article-title":"Formulation and evaluation of thermosensitive biogels for nose to brain delivery of doxepin","volume":"2014","author":"Naik","year":"2014","journal-title":"Biome"},{"key":"10.1016\/j.ijpharm.2019.02.026_b0700","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0378-5173(95)04416-7","article-title":"In vitro and in vivo nasal mucoadhesion of some water-soluble polymers","volume":"134","author":"Nakamura","year":"1996","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0705","doi-asserted-by":"crossref","first-page":"356","DOI":"10.5530\/jyp.2016.4.11","article-title":"Solubility enhancement of nebivolol by micro emulsion technique","volume":"8","author":"Nemichand","year":"2016","journal-title":"J. Young Pharm."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0710","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1208\/s12249-010-9522-9","article-title":"Validation of a static Franz diffusion cell system for in vitro permeation studies","volume":"11","author":"Ng","year":"2010","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijpharm.2019.02.026_b0715","series-title":"Handbook of Pharmaceutical Manufacturing Formulations: Liquid Products (Volume 3 of 6)","author":"Niazi","year":"2004"},{"key":"10.1016\/j.ijpharm.2019.02.026_b0720","series-title":"Handbook of Bioequivalence Testing","author":"Niazi","year":"2015"},{"key":"10.1016\/j.ijpharm.2019.02.026_b0725","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1002\/jps.10505","article-title":"The effect of various in vitro conditions on the permeability characteristics of the buccal mucosa","volume":"92","author":"Nicolazzo","year":"2003","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0730","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1055\/s-2007-1004876","article-title":"Biological activity of nasally administered insulin in normal subjects","volume":"22","author":"Nolte","year":"1990","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0735","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0013-9351(88)80056-2","article-title":"Toxicity of isopropyl alcohol exposure on the nasal mucociliary system in the guinea pig","volume":"46","author":"Ohashi","year":"1988","journal-title":"Environ. Res."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0740","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1021\/acs.molpharmaceut.5b00852","article-title":"Primary air-liquid interface culture of nasal epithelium for nasal drug delivery","volume":"13","author":"Ong","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0745","doi-asserted-by":"crossref","first-page":"3754","DOI":"10.3390\/molecules14093754","article-title":"Nasal delivery of high molecular weight drugs","volume":"14","author":"Ozsoy","year":"2009","journal-title":"Molecules"},{"key":"10.1016\/j.ijpharm.2019.02.026_b0750","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.ejps.2016.10.017","article-title":"Formulation, functional evaluation and ex vivo performance of thermoresponsive soluble gels \u2013 a platform for therapeutic delivery to mucosal sinus tissue","volume":"96","author":"Pandey","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0755","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1517\/17425247.2013.790887","article-title":"Direct nose to brain drug delivery via integrated nerves pathway bypassing the blood brain barrier:an excellent pathway for brain targetting","volume":"10","author":"Pardeshi","year":"2013","journal-title":"Exper. Opin. Drug Deliv."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0760","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4168\/aair.2016.8.1.69","article-title":"Alternative method for primary nasal epithelial cell culture using intranasal brushing and feasibility for the study of epithelial functions in allergic rhinitis","volume":"8","author":"Park","year":"2016","journal-title":"Allergy. Asthma Immunol. Res."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0765","doi-asserted-by":"crossref","DOI":"10.1007\/BF00178275","article-title":"The rheological characteristics of nasal mucus in patients with rhinitis","volume":"252","author":"Passali","year":"1995","journal-title":"Eur. Arch. Oto-Rhino-Laryngology"},{"key":"10.1016\/j.ijpharm.2019.02.026_b0770","article-title":"Formulation consideration and characterization of microemulsion drug delivery system for transnasal administration of carbamazepine","volume":"51","author":"Patel","year":"2013","journal-title":"Bull. Fac. Pharmacy, Cairo Univ."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0775","doi-asserted-by":"crossref","first-page":"62","DOI":"10.4103\/2230-973X.82383","article-title":"Mucoadhesion; a prerequisite or a constraint in nasal drug delivery?","volume":"1","author":"Pathak","year":"2011","journal-title":"Int. J. Pharm. Investig."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0780","unstructured":"Pathak, Y., Thassu, D. Drug Delivery Nanoparticles Formulation and Characterization, 2009."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0785","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.apsb.2014.02.002","article-title":"Role of mucoadhesive polymers in enhancing delivery of nimodipine microemulsion to brain via intranasal route","volume":"4","author":"Pathak","year":"2014","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ijpharm.2019.02.026_b0790","doi-asserted-by":"crossref","first-page":"64","DOI":"10.4103\/0250-474X.22966","article-title":"Preparation and in vitro evaluation of mucoadhesive chitosan microspheres of amlodipine besylate for nasal administration","volume":"68","author":"Patil","year":"2006","journal-title":"Indian J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0795","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3109\/10611861003663523","article-title":"Mucoadhesive chitosan microspheres of carvedilol for nasal administration","volume":"18","author":"Patil","year":"2010","journal-title":"J. Drug Target."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0800","doi-asserted-by":"crossref","first-page":"445","DOI":"10.3109\/02652049409034262","article-title":"Spray-dried albumin microspheres for the intra-articular delivery of dexamethasone","volume":"11","author":"Pavanetto","year":"1994","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0805","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/S0885-3924(02)00522-5","article-title":"Pilot study of nasal morphine-chitosan for the relief of breakthrough pain in patients with cancer","volume":"24","author":"Pavis","year":"2002","journal-title":"J. Pain Symptom Manage."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0810","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1208\/s12248-009-9169-1","article-title":"Evaluation of mucoadhesive PLGA microparticles for nasal immunization","volume":"12","author":"Pawar","year":"2010","journal-title":"AAPS J."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0815","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3109\/10717544.2014.908427","article-title":"Mucoadhesive glycol chitosan nanoparticles for intranasal delivery of hepatitis B vaccine: enhancement of mucosal and systemic immune response","volume":"23","author":"Pawar","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0820","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1080\/03639040802149046","article-title":"Spray pattern and droplet size analyses for high-shear viscosity determination of aqueous suspension corticosteroid nasal sprays","volume":"34","author":"Pennington","year":"2008","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0825","doi-asserted-by":"crossref","first-page":"288","DOI":"10.18433\/J3NC79","article-title":"Intranasal drug delivery: how, why and what for?","volume":"12","author":"Pires","year":"2009","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0830","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1467-2494.1992.tb00058.x","article-title":"In vitro cultured human skin cells as alternatives to animals for skin irritancy screening","volume":"14","author":"Ponec","year":"1992","journal-title":"Int. J. Cosmet. Sci."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0835","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ejpb.2016.07.010","article-title":"Application of RPMI 2650 nasal cell model to a 3D printed apparatus for the testing of drug deposition and permeation of nasal products","volume":"107","author":"Pozzoli","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0840","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.3109\/03639045.2016.1160110","article-title":"Dry powder nasal drug delivery: challenges, opportunities and a study of the commercial Teijin Puvlizer Rhinocort device and formulation","volume":"42","author":"Pozzoli","year":"2016","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0845","unstructured":"Pozzoli, M. et al., 2014. Optimization of RPMI 2650 Cells as a Model for Nasal Mucosa."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0850","unstructured":"Pozzoli, M., 2017. Drug delivery to the nose\u202f: formulation, deposition and permeation of poorly soluble drugs."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0855","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1080\/02786826.2014.931566","article-title":"A comparison of the deposition patterns of different nasal spray formulations using a nasal cast","volume":"48","author":"Pu","year":"2014","journal-title":"Aerosol Sci. Technol."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0860","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ejps.2012.10.029","article-title":"Ex vivo permeation characteristics of venlafaxine through sheep nasal mucosa","volume":"48","author":"Pund","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0865","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0378-5173(89)90229-9","article-title":"A novel in situ method to test polymers and coated microparticles for bioadhesion","volume":"52","author":"Rao","year":"1989","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0870","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1111\/j.2042-7158.2012.01540.x","article-title":"Cultivation of RPMI 2650 cells as an in-vitro model for human transmucosal nasal drug absorption studies: optimization of selected culture conditions","volume":"64","author":"Reichl","year":"2012","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0875","doi-asserted-by":"crossref","DOI":"10.3791\/3261","article-title":"Use of the EpiAirway model for characterizing long-term host-pathogen interactions","author":"Ren","year":"2011","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0880","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1001\/archotol.125.1.101","article-title":"Effects of mucokinetic drugs on rheological properties of reconstituted human nasal mucus","volume":"125","author":"Rhee","year":"1999","journal-title":"Arch. Otolaryngol. Neck Surg."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0885","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/jcp.20066","article-title":"N-acetylcysteine inhibits Na+ absorption across human nasal epithelial cells","volume":"201","author":"Rochat","year":"2004","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0890","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.ijpharm.2017.09.027","article-title":"A comprehensive screening platform for aerosolizable protein formulations for intranasal and pulmonary drug delivery","volume":"532","author":"R\u00f6hm","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0895","doi-asserted-by":"crossref","first-page":"8531","DOI":"10.2147\/IJN.S147650","article-title":"Development of coated liposomes loaded with ghrelin for nose-to-brain delivery for the treatment of cachexia","volume":"12","author":"Salade","year":"2017","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ijpharm.2019.02.026_b0900","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ejpb.2018.06.011","article-title":"Chitosan-coated liposome dry-powder formulations loaded with ghrelin for nose-to-brain delivery","volume":"129","author":"Salade","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0905","first-page":"66","article-title":"Particle size determination of nasal drug delivery system: a review","volume":"17","author":"Sangolkar","year":"2012","journal-title":"Int. J. Pharm. Sci. Rev. Res."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0910","unstructured":"Scherlie\u00df, R., 2010. Comparison of in vitro methods to determine nasal versus lung deposition of a protein formulation."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0915","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.provac.2011.07.016","article-title":"Novel formulation concept for particulate uptake of vaccines via the nasal associated lymphoid tissue","volume":"4","author":"Scherlie\u00df","year":"2011","journal-title":"Procedia Vaccinol."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0920","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1023\/A:1015830907632","article-title":"The nasal mucociliary clearance: relevance to nasal drug delivery","volume":"8","author":"Schipper","year":"1991","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0925","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/(SICI)1520-6017(200003)89:3<396::AID-JPS10>3.0.CO;2-F","article-title":"Validation of excised bovine nasal mucosa as in vitro model to study drug transport and metabolic pathways in nasal epithelium","volume":"89","author":"Schmidt","year":"2000","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0930","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0169-409X(97)00061-6","article-title":"In vitro cell models to study nasal mucosal permeability and metabolism","volume":"29","author":"Schmidt","year":"1998","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0935","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s12931-017-0706-7","article-title":"Characterization of pediatric cystic fibrosis airway epithelial cell cultures at the air-liquid interface obtained by non-invasive nasal cytology brush sampling","volume":"18","author":"Sch\u00f6gler","year":"2017","journal-title":"Respir. Res."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0940","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1089\/jamp.2013.1084","article-title":"Experimental measurements and computational predictions of regional particle deposition in a sectional nasal model","volume":"28","author":"Schroeter","year":"2015","journal-title":"J. Aerosol Med. Pulm. Drug Deliv."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0945","series-title":"Nanotechnology Methods for Neurological Diseases and Brain Tumors","first-page":"103","article-title":"Challenges of the nose-to-brain route","author":"Sekerdag","year":"2017"},{"key":"10.1016\/j.ijpharm.2019.02.026_b0950","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ijpharm.2007.02.004","article-title":"Effects of a sperminated gelatin on the nasal absorption of insulin","volume":"338","author":"Seki","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0955","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1089\/jamp.2012.1011","article-title":"Design of experiments to optimize an in vitro cast to predict human nasal drug deposition","volume":"27","author":"Shah","year":"2014","journal-title":"J. Aerosol Med. Pulm. Drug Deliv."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0960","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ejps.2016.05.008","article-title":"Non-invasive intranasal delivery of quetiapine fumarate loaded microemulsion for brain targeting: formulation, physicochemical and pharmacokinetic consideration","volume":"91","author":"Shah","year":"2016","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0965","doi-asserted-by":"crossref","first-page":"918","DOI":"10.3109\/10717544.2013.878857","article-title":"Nose to brain microemulsion-based drug delivery system of rivastigmine: formulation and ex-vivo characterization","volume":"22","author":"Shah","year":"2015","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0970","series-title":"Generic Drug Product Development: Specialty Drug Forms","author":"Shargel","year":"2010"},{"key":"10.1016\/j.ijpharm.2019.02.026_b0975","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1258\/0022215001906246","article-title":"Effect of packing on nasal mucosa of sheep","volume":"114","author":"Shaw","year":"2000","journal-title":"J. Laryngol. Otol."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0980","first-page":"L493","article-title":"Calu-3: a human airway epithelial cell line that shows cAMP-dependent Cl- secretion","volume":"266","author":"Shen","year":"1994","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0985","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jaerosci.2007.02.002","article-title":"Modeling of inertial particle transport and deposition in human nasal cavities with wall roughness","volume":"38","author":"Shi","year":"2007","journal-title":"J. Aerosol Sci."},{"key":"10.1016\/j.ijpharm.2019.02.026_b0990","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1248\/cpb.52.957","article-title":"Nasal absorption and pharmacokinetic disposition of salmon calcitonin modified with low molecular weight polyethylene glycol","volume":"52","author":"Shin","year":"2004","journal-title":"Chem. Pharm. Bull. (Tokyo)"},{"key":"10.1016\/j.ijpharm.2019.02.026_b0995","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0378-5173(81)90058-2","article-title":"Absorption of drugs from the nasal mucosa of rat","volume":"7","author":"Shinichiro","year":"1981","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2019.02.026_b1000","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ijpharm.2013.05.040","article-title":"Mucus as a barrier to lipophilic drugs","volume":"453","author":"Sigurdsson","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2019.02.026_b1005","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3390\/pharmaceutics10010034","article-title":"Surface-modified nanocarriers for nose-to-brain delivery: from bioadhesion to targeting","volume":"10","author":"Sonvico","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijpharm.2019.02.026_b1010","unstructured":"Spraytec Nasal Spray Support for accurate nasal spray droplet sizing from Malvern Instruments. Available at: https:\/\/www.malvernpanalytical.com\/en\/products\/product-range\/spraytec\/accessories\/nasal-spray-accessory. (Accessed: 19th September 2018)."},{"key":"10.1016\/j.ijpharm.2019.02.026_b1015","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/2211068214561025","article-title":"TEER measurement techniques for in vitro barrier model systems","volume":"20","author":"Srinivasan","year":"2015","journal-title":"J. Lab. Autom."},{"key":"10.1016\/j.ijpharm.2019.02.026_b1020","doi-asserted-by":"crossref","DOI":"10.1136\/thx.41.7.519","article-title":"Effect of cigarette smoking on nasal mucociliary clearance and ciliary beat frequency","volume":"41","author":"Stanley","year":"1986","journal-title":"Thorax"},{"key":"10.1016\/j.ijpharm.2019.02.026_b1025","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1526-4637.2007.00300.x","article-title":"Analgesic efficacy and safety of morphine-chitosan nasal solution in patients with moderate to severe pain following orthopedic surgery","volume":"9","author":"Stoker","year":"2008","journal-title":"Pain Med."},{"key":"10.1016\/j.ijpharm.2019.02.026_b1030","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/089583798197772","article-title":"Computational fluid dynamics simulations of inspiratory airflow in the human nose and nasopharynx","volume":"10","author":"Subramaniam","year":"1998","journal-title":"Inhal. Toxicol."},{"key":"10.1016\/j.ijpharm.2019.02.026_b1035","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1023\/A:1011933410898","article-title":"Comparison of nasal deposition and clearance of aerosol generated by nebulizer and an aqueous spray pump","volume":"16","author":"Suman","year":"1999","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2019.02.026_b1040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/A:1013643912335","article-title":"Validity of in vitro tests on aqueous spray pumps as surrogates for nasal deposition","volume":"19","author":"Suman","year":"2002","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2019.02.026_b1045","doi-asserted-by":"crossref","first-page":"608","DOI":"10.4103\/0250-474X.100233","article-title":"Preparation and in vitro characterization of mucoadhesive hydroxypropyl guar microspheres containing amlodipine besylate for nasal administration","volume":"73","author":"Swamy","year":"2011","journal-title":"Indian J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2019.02.026_b1050","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1023\/A:1016009313548","article-title":"Enteral absorption of insulin in rats from mucoadhesive chitosan-coated liposomes","volume":"13","author":"Takeuchi","year":"1996","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2019.02.026_b1055","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/10717540902764172","article-title":"Nasal administration of metoclopramide from different dosage forms: in vitro, ex vivo, and in vivo evaluation","volume":"16","author":"Tas","year":"2009","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ijpharm.2019.02.026_b1060","article-title":"IgA polymerization contributes to efficient virus neutralization on human upper respiratory mucosa after intranasal inactivated influenza vaccine administration","volume":"00\u201300","author":"Terauchi","year":"2018","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.ijpharm.2019.02.026_b1065","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1574-695X.2007.00220.x","article-title":"Structural modification of a base disaccharide alters antiadhesion properties towards Yersinia pestis","volume":"49","author":"Thomas","year":"2007","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.1016\/j.ijpharm.2019.02.026_b1070","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ejps.2017.09.027","article-title":"Opportunity and challenges of nasal powders: drug formulation and delivery.","volume":"113","author":"Tiozzo Fasiolo","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2019.02.026_b1075","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3390\/pharmaceutics6020195","article-title":"Analytical challenges and regulatory requirements for nasal drug products in Europe and the U.S.","volume":"6","author":"Trows","year":"2014","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijpharm.2019.02.026_b1080","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1023\/B:PHAR.0000026823.82950.ff","article-title":"Nasal route and drug delivery systems","volume":"26","author":"T\u00fcrker","year":"2004","journal-title":"Pharm. World Sci."},{"key":"10.1016\/j.ijpharm.2019.02.026_b1085","doi-asserted-by":"crossref","DOI":"10.3791\/53814","article-title":"Cultivate primary nasal epithelial cells from children and reprogram into induced pluripotent stem cells","author":"Ulm","year":"2016","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.ijpharm.2019.02.026_b1090","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1080\/10717540802006377","article-title":"Permeation studies and histological examination of sheep nasal mucosa following administration of different nasal formulations with or without absorption enhancers","volume":"15","author":"Ument Karasulu","year":"2008","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ijpharm.2019.02.026_b1095","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.jsps.2016.07.003","article-title":"Direct and enhanced delivery of nanoliposomes of anti schizophrenic agent to the brain through nasal route","volume":"25","author":"Upadhyay","year":"2017","journal-title":"Saudi Pharm. J."},{"key":"10.1016\/j.ijpharm.2019.02.026_b1100","series-title":"Peptide and Protein Delivery","author":"Van der Walle","year":"2011"},{"key":"10.1016\/j.ijpharm.2019.02.026_b1105","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.3390\/cancers5031020","article-title":"Formulations for intranasal delivery of pharmacological agents to combat brain disease: a new opportunity to tackle GBM?","volume":"5","author":"van Woensel","year":"2013","journal-title":"Cancers (Basel)."},{"key":"10.1016\/j.ijpharm.2019.02.026_b1110","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/10717540500309040","article-title":"Nasal delivery of insulin using bioadhesive chitosan gels","volume":"13","author":"Varshosaz","year":"2006","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ijpharm.2019.02.026_b1115","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1208\/s12249-016-0581-4","article-title":"Improved flux of levodopa via direct deposition of solid microparticles on nasal tissue","volume":"18","author":"Vasa","year":"2017","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijpharm.2019.02.026_b1120","first-page":"61","article-title":"Development and application of an ex vivo fosphenytoin nasal bioconversion\/permeability evaluation method","volume":"89","author":"Viegas","year":"2016","journal-title":"PHASCI"},{"key":"10.1016\/j.ijpharm.2019.02.026_b1125","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1034\/j.1399-3003.2000.01514.x","article-title":"Tight junction properties of the immortalized human bronchial epithelial cell lines Calu-3 and 16HBE14o-","volume":"15","author":"Wan","year":"2000","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ijpharm.2019.02.026_b1130","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1016\/j.xphs.2016.03.035","article-title":"Zolpidem mucoadhesive formulations for intranasal delivery: characterization, in vitro permeability, pharmacokinetics, and nasal ciliotoxicity in rats","volume":"105","author":"Wang","year":"2016","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2019.02.026_b1135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0189478","article-title":"A mucoadhesive, thermoreversible in situ nasal gel of geniposide for neurodegenerative diseases","volume":"12","author":"Wang","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ijpharm.2019.02.026_b1140","first-page":"497","article-title":"Olfactory targeting through intranasal delivery of biopharmaceutical drugs to the brain: current development","volume":"11","author":"Wen","year":"2011","journal-title":"Discov. Med."},{"key":"10.1016\/j.ijpharm.2019.02.026_b1145","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.ejpb.2009.08.008","article-title":"RPMI 2650 epithelial model and three-dimensional reconstructed human nasal mucosa as in vitro models for nasal permeation studies","volume":"74","author":"Wengst","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2019.02.026_b1150","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.1208\/s12249-018-1179-9","article-title":"Evaluation of nasal inlet ports having simplified geometry for the pharmacopeial assessment of mass fraction of dose likely to penetrate beyond the nasopharynx: a preliminary investigation","volume":"19","author":"Williams","year":"2018","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijpharm.2019.02.026_b1155","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1177\/000348947608500311","article-title":"Rapid, Atraumatic method for obtaining nasal mucus samples","volume":"85","author":"Wilson","year":"1976","journal-title":"Ann. Otol. Rhinol. Laryngol."},{"key":"10.1016\/j.ijpharm.2019.02.026_b1160","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1023\/A:1018869601502","article-title":"In vitro evaluation of microparticles and polymer gels for use as nasal platforms for protein delivery","volume":"16","author":"Witschi","year":"1999","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2019.02.026_b1165","first-page":"311","article-title":"Growth and differentiation of human nasal epithelial cells in culture. Serum-free, hormone-supplemented medium and proteoglycan synthesis","volume":"132","author":"Wu","year":"1985","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.ijpharm.2019.02.026_b1170","first-page":"1527","article-title":"Visualization and quantification of nasal and olfactory deposition in a sectional adult nasal airway cast","volume":"33","author":"Xi","year":"2016","journal-title":"Pharm. Res. An Off. J. Am. Assoc. Pharm. Sci. Pharm Res"},{"key":"10.1016\/j.ijpharm.2019.02.026_b1175","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jaerosci.2016.01.013","article-title":"Modeling of inertial deposition in scaled models of rat and human nasal airways: towards in vitro regional dosimetry in small animals","volume":"99","author":"Xi","year":"2016","journal-title":"J. Aerosol Sci."},{"key":"10.1016\/j.ijpharm.2019.02.026_b1180","series-title":"Advanced Technology for Delivering Therapeutics","article-title":"Numerical simulation and experimental testing to improve olfactory drug delivery with electric field guidance of charged particles","author":"Xi","year":"2017"},{"key":"10.1016\/j.ijpharm.2019.02.026_b1185","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1248\/cpb.54.48","article-title":"Preparation of bupleurum nasal spray and evaluation on its safety and efficacy","volume":"54","author":"Xie","year":"2006","journal-title":"Chem. Pharm. Bull. (Tokyo)"},{"key":"10.1016\/j.ijpharm.2019.02.026_b1190","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.carbpol.2017.01.044","article-title":"Formulation of olfactory-targeted microparticles with tamarind seed polysaccharide to improve nose-to-brain transport of drugs","volume":"163","author":"Yarragudi","year":"2017","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ijpharm.2019.02.026_b1195","doi-asserted-by":"crossref","first-page":"474","DOI":"10.3109\/1061186X.2013.766885","article-title":"DNA-loaded chitosan oligosaccharide nanoparticles with enhanced permeability across Calu-3 cells","volume":"21","author":"Ye","year":"2013","journal-title":"J. Drug Target."},{"key":"10.1016\/j.ijpharm.2019.02.026_b1200","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1023\/A:1026112107100","article-title":"Serially passaged human nasal epithelial cell monolayer for in vitro drug transport studies","volume":"20","author":"Yoo","year":"2003","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2019.02.026_b1205","series-title":"Mucosal Delivery of Biopharmaceuticals","first-page":"35","article-title":"Mucoadhesion and characterization of mucoadhesive properties","author":"Yu","year":"2014"},{"key":"10.1016\/j.ijpharm.2019.02.026_b1210","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1080\/02786829808965517","article-title":"Fluid Flow and Particle Diffusion in the Human Upper Respiratory System","volume":"28","author":"Yu","year":"1998","journal-title":"Aerosol Sci. Technol."},{"key":"10.1016\/j.ijpharm.2019.02.026_b1215","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1111\/j.1745-7254.2005.00174.x","article-title":"Permeation-enhancing effects of chitosan formulations on recombinant hirudin-2 by nasal delivery in vitro and in vivo","volume":"26","author":"Zhang","year":"2005","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ijpharm.2019.02.026_b1220","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.2147\/DDDT.S110247","article-title":"Puerarin transport across a Calu-3 cell monolayer \u2013 an in vitro model of nasal mucosa permeability and the influence of paeoniflorin and menthol","volume":"10","author":"Zhang","year":"2016","journal-title":"Drug Des. Devel. Ther."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517319301498?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517319301498?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T09:36:36Z","timestamp":1759916196000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517319301498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":244,"alternative-id":["S0378517319301498"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2019.02.026","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"How to characterize a nasal product. The state of the art of in vitro and ex vivo specific methods","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2019.02.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}